VEGFA and age-related macular degeneration: Additionally, anti-VEGF treatments may exhibit neuroprotective properties [5] beyond vascular effects, where reduced oxidative stress and inflammation in one eye could create a favorable environment for retinal cells in both eyes, particularly significant in AMD, which typically manifests as a bilateral disease.